People · Operator

David F Hale

Named in public records as an officer, director or promoter · active 2009–2021 · Biotechnology, Healthtech, Other Health Care, Pharmaceuticals

16
Companies
70
Filings
$801.0M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Neurelis, Inc.BiotechnologySeries D+$221.8M$3.8B2010
Oncternal Therapeutics, Inc.BiotechnologySeries C$186.1M$222.9M2014
Histogen Inc.BiotechnologySeries B$94.9M$82.9M2010
Clarify Medical, Inc.HealthtechSeries C$67.6M$776.1M2014
Colorescience IncOther Health CareSeries B$51.2M$66.5M2013
Neurana Pharmaceuticals, Inc.BiotechnologySeries C$45.7M$1.7B2013
Biocept IncBiotechnologySeries A$35.7M$366.4M2015
Skinmedica IncPharmaceuticalsSeries B$26.2M$569.9M2009
Adigica Health, Inc.HealthtechSeries A$21.8M$18.2M2016
Dermata Therapeutics, LLCBiotechnologySeries A$16.2M$106.3M2014
Recros Medica, Inc.BiotechnologySeries A$9.9M$149.0M2014
Ridge Diagnostics, Inc.BiotechnologySeries A$7.4M$9.0M2010
Mdrejuvena, Inc.BiotechnologySeed$6.2M$107.5M2014
Somaxon Pharmaceuticals, Inc.PharmaceuticalsSeries A$6.0M$185.8M2009
Idun Pharmaceuticals IncPharmaceuticalsSeed$3.9M$42.8M2014
Agility Clinical, Inc.Other Health CarePre-Seed$390K$12.0M2012
Operator network

David F Hale at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Charles J. Cashion · 2 companies · 2 sharedCharles J. CashionCam L. Garner · 11 companies · 3 sharedCam L. GarnerRichard W. Pascoe · 4 companies · 2 sharedRichard W. PascoeWilliam R. LaRue · 3 companies · 2 sharedWilliam R. LaRueScott L. Glenn · 9 companies · 1 sharedScott L. GlennDavid B. Johnson · 6 companies · 1 sharedDavid B. JohnsonPAUL LAVIOLETTE · 12 companies · 1 sharedPAUL LAVIOLETTERobert Garber · 8 companies · 1 sharedRobert GarberBruce Robertson · 7 companies · 1 sharedBruce RobertsonAlex Morgan · 10 companies · 1 sharedAlex MorganAdele Oliva · 9 companies · 1 sharedAdele OlivaJosh Baltzell · 7 companies · 1 sharedJosh BaltzellDavid Hale · 4 companies · 2 sharedDavid HaleRex Bright · 3 companies · 2 sharedRex BrightBrian H. Dovey · 7 companies · 2 sharedBrian H. DoveyJames H. Cavanaugh, Ph.D. · 3 companies · 2 sharedJames H. Cavanaug…Mary Fisher · 3 companies · 2 sharedMary FisherTheodore Ebel · 2 companies · 2 sharedTheodore EbelTodd Johnson · 27 companies · 1 sharedTodd JohnsonIvor Royston · 7 companies · 1 sharedIvor RoystonKathleen D. Scott · 5 companies · 4 sharedKathleen D. ScottGerald T. Proehl · 5 companies · 2 sharedGerald T. ProehlNeurelis, Inc. · $221.8M raisedNeurelis, Inc.Oncternal Therapeutics, Inc. · $186.1M raisedOncternal Therapeutic…Histogen Inc. · $94.9M raisedHistogen Inc.Clarify Medical, Inc. · $67.6M raisedClarify Medical, Inc.Colorescience Inc · $51.2M raisedColorescience IncNeurana Pharmaceuticals, Inc. · $45.7M raisedNeurana Pharmaceutica…Biocept Inc · $35.7M raisedBiocept IncSkinmedica Inc · $26.2M raisedSkinmedica IncAdigica Health, Inc. · $21.8M raisedAdigica Health, Inc.Dermata Therapeutics, LLC · $16.2M raisedDermata Therapeutics,…Recros Medica, Inc. · $9.9M raisedRecros Medica, Inc.Ridge Diagnostics, Inc. · $7.4M raisedRidge Diagnostics, In…Mdrejuvena, Inc. · $6.2M raisedMdrejuvena, Inc.Somaxon Pharmaceuticals, Inc. · $6.0M raisedSomaxon Pharmaceutica…David F HaleDH
David F Hale Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside David F Hale on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Kathleen D. Scott45
Cam L. Garner311
Brian H. Dovey27
Gerald T. Proehl25
David Hale24
Richard W. Pascoe24
Rex Bright23
James H. Cavanaugh, Ph.D.23
William R. LaRue23
Mary Fisher23
Shahzad F. Malik22
Paul F. Klingenstein22
Louis F. Lacasse22
Theodore Ebel22
STEVEN J. MENTO, PH.D.22
Charles J. Cashion22
WILLIAM F. GERBER, M.D.22
Todd Johnson127
PAUL LAVIOLETTE112
Alex Morgan110

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.